15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT02021370
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 121 participants
- Sponsor
- Registry
-
NCT02021370 -
2013-001193-14
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Bulgaria, France, Germany, Hungary, Israel, Italy, Japan, Poland, Romania, South Korea, Spain, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02021370. Randomized; quadruple masking; primary purpose treatment. Start 2014-02-10 (actual); primary completion 2015-09-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
- Acronym
- DIALOGUE 1
- Condition
- Anemia
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- BAY85-3934
- Intervention (Drug)
- Placebo
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct02021370- Content hash
71ce0a30521d4de9bf9ade8f5bd2b2065fb6c62fda5316661622c1aad7d93285